News & Updates

Findings from the phase IIb/III ATTENTION-AD study reflect the continued benefit of oral blarcamesine in individuals with early Alzheimer’s disease (AD) after receiving the drug continuously for up to 4 years.

Early use of antibiotics among children may lead to several health concerns, including asthma and later infections during childhood years, suggests a study.

An 80-year-old Chinese male, a long-term smoker with no signif­icant medical history, was found to have a right lung mass on a routine chest X-ray in August 2021. A CT scan of the chest revealed a domi­nant right lower lobe mass (3.3 x 2.3 x 2.7 cm) with multiple bilateral lung nodules. CT-guided fine needle aspiration cytology (FNAC) of the right lower lobe mass performed on 2 December 2021 confirmed adeno­carcinoma, while a PET-CT scan on 10 January 2022 showed a right low­er lobe tumour with metastases to the left hilar and mediastinal lymph nodes and both lungs. (Figure 1A) Next-generation sequencing (OncoSnap Nonet) identified MET exon 14 (ME­Tex14) skipping mutation. The pro­grammed death ligand 1 (PD-L1) tumour proportion score (TPS) was 0 percent. The patient was diagnosed with stage IV non-small-cell lung can­cer (NSCLC) harbouring a METex14 skipping mutation. His Eastern Coop­erative Oncology Group performance status (ECOG PS) was 0.